Matthew D. Park

5.2k total citations · 2 hit papers
18 papers, 848 citations indexed

About

Matthew D. Park is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Matthew D. Park has authored 18 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Matthew D. Park's work include Immune cells in cancer (7 papers), COVID-19 Clinical Research Studies (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Matthew D. Park is often cited by papers focused on Immune cells in cancer (7 papers), COVID-19 Clinical Research Studies (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Matthew D. Park collaborates with scholars based in United States, Australia and Singapore. Matthew D. Park's co-authors include Miriam Mérad, Aymeric Silvin, Florent Ginhoux, Michaël Otto, Katherine Le, Thuan Nguyen, Meriem Belabed, Raphaël Mattiuz, Chang Moon and Daniel J. Puleston and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Matthew D. Park

18 papers receiving 838 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophages in health and disease

2022 353 citations Matthew D. Park, Aymeric Silvin et al. Cell profile →
Dendritic cell maturation in cancer

2025 37 citations Chang Moon, Meriem Belabed et al. Nature reviews. Cancer profile →

Peers

Matthew D. Park

IMMUN

MB

ID

ONCOL

NEURO

Kerry L. Hilligan New Zealand

Laura Migliari Branco Brazil

Mingfu Tian China

Christine D. Palmer United States

Parisa Zafari Iran

Edward G. Spack United States

Leslie Chávez‐Galán Mexico

Bérengère Villeret France

Garret L. Hayes United States

Stefanie Dichtl Austria

Kerry L. Hilligan New Zealand

Matthew D. Park

411 ×1.3

IMMUN

191 ×0.7

MB

159 ×0.8

ID

77 ×0.8

ONCOL

47 ×0.6

NEURO

Citations per year, relative to Matthew D. Park Matthew D. Park (= 1×) peers Kerry L. Hilligan

Countries citing papers authored by Matthew D. Park

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Park more than expected).

Fields of papers citing papers by Matthew D. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Park. The network helps show where Matthew D. Park may publish in the future.

Co-authorship network of co-authors of Matthew D. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Park. A scholar is included among the top collaborators of Matthew D. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Park. Matthew D. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Humblin, Étienne, Nataliya Prokhnevska, Abishek Vaidya, et al.. (2025). The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1+CD8+ T cells. Immunity. 58(8). 1966–1983.e10. 4 indexed citations

2.

Moon, Chang, Meriem Belabed, Matthew D. Park, et al.. (2025). Dendritic cell maturation in cancer. Nature reviews. Cancer. 25(4). 225–248. 37 indexed citations breakdown →

3.

Park, Matthew D., Nader Yatim, Jing Zhang, et al.. (2025). Restoring resident tissue macrophages to combat aging and cancer. Nature Aging. 5(8). 1383–1392. 2 indexed citations

4.

Dalla, Erica, Michael Papanicolaou, Matthew D. Park, et al.. (2024). Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell. 187(23). 6631–6648.e20. 18 indexed citations

5.

Mollaoglu, Gürkan, Alexander Tepper, Chiara Falcomatà, et al.. (2024). Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 187(26). 7492–7510.e22. 33 indexed citations

6.

Park, Matthew D., Meriem Belabed, Steven T. Chen, et al.. (2023). On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer. 7(1). 291–311. 10 indexed citations

7.

Park, Matthew D., Aymeric Silvin, Florent Ginhoux, & Miriam Mérad. (2022). Macrophages in health and disease. Cell. 185(23). 4259–4279. 353 indexed citations breakdown →

8.

Park, Matthew D. & Miriam Mérad. (2021). Cooperation between the alveolar epithelium and lung-resident basophils shapes alveolar macrophages. Nature reviews. Immunology. 21(6). 344–344. 2 indexed citations

9.

Martinez, Sarah, Eveline E. Vietsch, Marcel O. Schmidt, et al.. (2021). Cardiomyocyte-Specific Circulating Cell-Free Methylated DNA in Esophageal Cancer Patients Treated with Chemoradiation. SHILAP Revista de lepidopterología. 3(3). 100–112. 2 indexed citations

10.

Park, Matthew D.. (2020). Type I and type III interferon in opposition?. Nature reviews. Immunology. 20(7). 406–406. 1 indexed citations

11.

Park, Matthew D.. (2020). IgGs drive COVID-19 myeloid hyperinflammation. Nature reviews. Immunology. 20(9). 521–521. 1 indexed citations

12.

Park, Matthew D.. (2020). Immune evasion via SARS-CoV-2 ORF8 protein?. Nature reviews. Immunology. 20(7). 408–408. 35 indexed citations

13.

Park, Matthew D.. (2020). Sex differences in immune responses in COVID-19. Nature reviews. Immunology. 20(8). 461–461. 26 indexed citations

14.

Park, Matthew D.. (2020). COVID-19 and influenza: preparing for the storm. Nature reviews. Immunology. 20(8). 463–463. 1 indexed citations

15.

Park, Matthew D.. (2020). Macrophages: a Trojan horse in COVID-19?. Nature reviews. Immunology. 20(6). 351–351. 123 indexed citations

16.

Park, Matthew D.. (2020). Fatty monocytes in COVID-19. Nature reviews. Immunology. 20(11). 649–649. 1 indexed citations

17.

Le, Katherine, Matthew D. Park, & Michaël Otto. (2018). Immune Evasion Mechanisms of Staphylococcus epidermidis Biofilm Infection. Frontiers in Microbiology. 9. 359–359. 113 indexed citations

18.

Nguyen, Thuan, Matthew D. Park, & Michaël Otto. (2017). Host Response to Staphylococcus epidermidis Colonization and Infections. Frontiers in Cellular and Infection Microbiology. 7. 90–90. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact